Cargando…
Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients
OBJECTIVES: The purpose of this study was to validate computed tomography measured ECV (ECV(CT)) as part of routine evaluation for the detection of cardiac amyloid in patients with aortic stenosis (AS)-amyloid. BACKGROUND: AS-amyloid affects 1 in 7 elderly patients referred for transcatheter aortic...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536272/ https://www.ncbi.nlm.nih.gov/pubmed/32771574 http://dx.doi.org/10.1016/j.jcmg.2020.05.029 |
_version_ | 1783590530649686016 |
---|---|
author | Scully, Paul R. Patel, Kush P. Saberwal, Bunny Klotz, Ernst Augusto, João B. Thornton, George D. Hughes, Rebecca K. Manisty, Charlotte Lloyd, Guy Newton, James D. Sabharwal, Nikant Kelion, Andrew Kennon, Simon Ozkor, Muhiddin Mullen, Michael Hartman, Neil Cavalcante, João L. Menezes, Leon J. Hawkins, Philip N. Treibel, Thomas A. Moon, James C. Pugliese, Francesca |
author_facet | Scully, Paul R. Patel, Kush P. Saberwal, Bunny Klotz, Ernst Augusto, João B. Thornton, George D. Hughes, Rebecca K. Manisty, Charlotte Lloyd, Guy Newton, James D. Sabharwal, Nikant Kelion, Andrew Kennon, Simon Ozkor, Muhiddin Mullen, Michael Hartman, Neil Cavalcante, João L. Menezes, Leon J. Hawkins, Philip N. Treibel, Thomas A. Moon, James C. Pugliese, Francesca |
author_sort | Scully, Paul R. |
collection | PubMed |
description | OBJECTIVES: The purpose of this study was to validate computed tomography measured ECV (ECV(CT)) as part of routine evaluation for the detection of cardiac amyloid in patients with aortic stenosis (AS)-amyloid. BACKGROUND: AS-amyloid affects 1 in 7 elderly patients referred for transcatheter aortic valve replacement (TAVR). Bone scintigraphy with exclusion of a plasma cell dyscrasia can diagnose transthyretin-related cardiac amyloid noninvasively, for which novel treatments are emerging. Amyloid interstitial expansion increases the myocardial extracellular volume (ECV). METHODS: Patients with severe AS underwent bone scintigraphy (Perugini grade 0, negative; Perugini grades 1 to 3, increasingly positive) and routine TAVR evaluation CT imaging with ECV(CT) using 3- and 5-min post-contrast acquisitions. Twenty non-AS control patients also had ECV(CT) performed using the 5-min post-contrast acquisition. RESULTS: A total of 109 patients (43% male; mean age 86 ± 5 years) with severe AS and 20 control subjects were recruited. Sixteen (15%) had AS-amyloid on bone scintigraphy (grade 1, n = 5; grade 2, n = 11). ECV(CT) was 32 ± 3%, 34 ± 4%, and 43 ± 6% in Perugini grades 0, 1, and 2, respectively (p < 0.001 for trend) with control subjects lower than lone AS (28 ± 2%; p < 0.001). ECV(CT) accuracy for AS-amyloid detection versus lone AS was 0.87 (0.95 for (99m)Tc-3,3-diphosphono-1,2-propanodicarboxylic acid Perugini grade 2 only), outperforming conventional electrocardiogram and echocardiography parameters. One composite parameter, the voltage/mass ratio, had utility (similar AUC of 0.87 for any cardiac amyloid detection), although in one-third of patients, this could not be calculated due to bundle branch block or ventricular paced rhythm. CONCLUSIONS: ECV(CT) during routine CT TAVR evaluation can reliably detect AS-amyloid, and the measured ECV(CT) tracks the degree of infiltration. Another measure of interstitial expansion, the voltage/mass ratio, also performed well. |
format | Online Article Text |
id | pubmed-7536272 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-75362722020-10-07 Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients Scully, Paul R. Patel, Kush P. Saberwal, Bunny Klotz, Ernst Augusto, João B. Thornton, George D. Hughes, Rebecca K. Manisty, Charlotte Lloyd, Guy Newton, James D. Sabharwal, Nikant Kelion, Andrew Kennon, Simon Ozkor, Muhiddin Mullen, Michael Hartman, Neil Cavalcante, João L. Menezes, Leon J. Hawkins, Philip N. Treibel, Thomas A. Moon, James C. Pugliese, Francesca JACC Cardiovasc Imaging Original Research OBJECTIVES: The purpose of this study was to validate computed tomography measured ECV (ECV(CT)) as part of routine evaluation for the detection of cardiac amyloid in patients with aortic stenosis (AS)-amyloid. BACKGROUND: AS-amyloid affects 1 in 7 elderly patients referred for transcatheter aortic valve replacement (TAVR). Bone scintigraphy with exclusion of a plasma cell dyscrasia can diagnose transthyretin-related cardiac amyloid noninvasively, for which novel treatments are emerging. Amyloid interstitial expansion increases the myocardial extracellular volume (ECV). METHODS: Patients with severe AS underwent bone scintigraphy (Perugini grade 0, negative; Perugini grades 1 to 3, increasingly positive) and routine TAVR evaluation CT imaging with ECV(CT) using 3- and 5-min post-contrast acquisitions. Twenty non-AS control patients also had ECV(CT) performed using the 5-min post-contrast acquisition. RESULTS: A total of 109 patients (43% male; mean age 86 ± 5 years) with severe AS and 20 control subjects were recruited. Sixteen (15%) had AS-amyloid on bone scintigraphy (grade 1, n = 5; grade 2, n = 11). ECV(CT) was 32 ± 3%, 34 ± 4%, and 43 ± 6% in Perugini grades 0, 1, and 2, respectively (p < 0.001 for trend) with control subjects lower than lone AS (28 ± 2%; p < 0.001). ECV(CT) accuracy for AS-amyloid detection versus lone AS was 0.87 (0.95 for (99m)Tc-3,3-diphosphono-1,2-propanodicarboxylic acid Perugini grade 2 only), outperforming conventional electrocardiogram and echocardiography parameters. One composite parameter, the voltage/mass ratio, had utility (similar AUC of 0.87 for any cardiac amyloid detection), although in one-third of patients, this could not be calculated due to bundle branch block or ventricular paced rhythm. CONCLUSIONS: ECV(CT) during routine CT TAVR evaluation can reliably detect AS-amyloid, and the measured ECV(CT) tracks the degree of infiltration. Another measure of interstitial expansion, the voltage/mass ratio, also performed well. Elsevier 2020-10 /pmc/articles/PMC7536272/ /pubmed/32771574 http://dx.doi.org/10.1016/j.jcmg.2020.05.029 Text en © 2020 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Research Scully, Paul R. Patel, Kush P. Saberwal, Bunny Klotz, Ernst Augusto, João B. Thornton, George D. Hughes, Rebecca K. Manisty, Charlotte Lloyd, Guy Newton, James D. Sabharwal, Nikant Kelion, Andrew Kennon, Simon Ozkor, Muhiddin Mullen, Michael Hartman, Neil Cavalcante, João L. Menezes, Leon J. Hawkins, Philip N. Treibel, Thomas A. Moon, James C. Pugliese, Francesca Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients |
title | Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients |
title_full | Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients |
title_fullStr | Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients |
title_full_unstemmed | Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients |
title_short | Identifying Cardiac Amyloid in Aortic Stenosis: ECV Quantification by CT in TAVR Patients |
title_sort | identifying cardiac amyloid in aortic stenosis: ecv quantification by ct in tavr patients |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536272/ https://www.ncbi.nlm.nih.gov/pubmed/32771574 http://dx.doi.org/10.1016/j.jcmg.2020.05.029 |
work_keys_str_mv | AT scullypaulr identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT patelkushp identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT saberwalbunny identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT klotzernst identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT augustojoaob identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT thorntongeorged identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT hughesrebeccak identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT manistycharlotte identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT lloydguy identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT newtonjamesd identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT sabharwalnikant identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT kelionandrew identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT kennonsimon identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT ozkormuhiddin identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT mullenmichael identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT hartmanneil identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT cavalcantejoaol identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT menezesleonj identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT hawkinsphilipn identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT treibelthomasa identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT moonjamesc identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients AT pugliesefrancesca identifyingcardiacamyloidinaorticstenosisecvquantificationbyctintavrpatients |